Fundraising Fox
fusion-antibodies
Northern Ireland, GB · Founded 2001 · 30 employees on LinkedIn · 1 known investors
Find your way into fusion-antibodies
Sign up to see every warm intro you have to fusion-antibodies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the fusion-antibodies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fusion Antibodies optimizes antibody development for research and therapeutic applications. The company serves pharmaceutical and biotech customers seeking to enhance antibody performance.
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- FUSION ANTIBODIES PLC
- Company number
- NI039740
- Status
- Active
- Company type
- Public limited company
- Incorporated
- 29 Nov 2000
- Registered office
- 1 Springbank Road, Springbank Industrial Estate, Belfast, BT17 0QL
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology74909 — Other professional, scientific and technical activities n.e.c.
- Previous names
- FUSION ANTIBODIES LIMITED (2000–2017)
- Accounts
- last made up to 31 Mar 2025 · next due 30 Sept 2026
- Confirmation statement
- last made up to 20 Jan 2026 · next due 3 Feb 2027
Current officers · 7
- Stephen Barry Smyth — secretary, appointed 16 Sept 2023
- Matthew Paul Baker — director, appointed 1 Mar 2022
- Richard Buick — director, appointed 15 Aug 2011
- Simon Gordon Douglas — director, appointed 7 Sept 2006
- Adrian Robert Kinkaid — director, appointed 25 Aug 2022
- Stephen Barry Smyth — director, appointed 13 Sept 2023
- Colin James Walsh — director, appointed 3 Jul 2007
Source: Companies House public register · retrieved 13 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does fusion-antibodies do?
- Fusion Antibodies optimizes antibody development for research and therapeutic applications. The company serves pharmaceutical and biotech customers seeking to enhance antibody performance.
- Who are fusion-antibodies's investors?
- fusion-antibodies's investors include Clarendon Fund Managers Ltd..
- Where is fusion-antibodies headquartered?
- fusion-antibodies is headquartered in Northern Ireland, GB.